https://www.cancernetwork.com/view/one-of-the-best-opportunities-for-long-term-remission-in-multiple-myeloma2026-08-16https://cdn.sanity.io/images/0vv8moc6/cancernetwork/66771ddad582df1a2df15d62063977ab11c786db-1920x1080.pnghttps://players.brightcove.net/10203567001/dDZp7kuoR_default/index.html?videoId=6402921549112 https://www.cancernetwork.com/view/defining-the-objectives-of-an-analysis-of-tarlatamab-in-brain-metastases2026-08-15https://cdn.sanity.io/images/0vv8moc6/cancernetwork/153aebd3f239f0d6da54014879209548df2b5591-1920x1080.pnghttps://players.brightcove.net/10203567001/dDZp7kuoR_default/index.html?videoId=6403461677112 https://www.cancernetwork.com/view/what-are-the-biggest-misconceptions-about-car-t-cells-in-multiple-myeloma-2026-08-15https://cdn.sanity.io/images/0vv8moc6/cancernetwork/c0cd8a12a9161c5a818f0c250a9ea2c7fecdf721-1920x1080.pnghttps://players.brightcove.net/10203567001/dDZp7kuoR_default/index.html?videoId=6402923591112 https://www.cancernetwork.com/view/the-rationale-for-jak-inhibition-pd-1-blockade-in-immune-resistant-rcc2026-08-15https://cdn.sanity.io/images/0vv8moc6/cancernetwork/9c541bbf84fd717563c88d99a3739ede9d7e2e1a-1920x1080.pnghttps://players.brightcove.net/10203567001/dDZp7kuoR_default/index.html?videoId=6403229925112 https://www.cancernetwork.com/view/ensuring-access-to-car-t-cells-among-rural-multiple-myeloma-populations2026-08-14https://cdn.sanity.io/images/0vv8moc6/cancernetwork/65556d9bde96f6f23265b79c00ac483b6682726d-1920x1080.pnghttps://players.brightcove.net/10203567001/dDZp7kuoR_default/index.html?videoId=6402922312112 https://www.cancernetwork.com/view/debating-frontline-choice-for-child-pugh-a-bclc-c-bulky-disease2026-08-14https://cdn.sanity.io/images/0vv8moc6/cancernetwork/cabf8c772800a6812c20411dc26c291b2ee759d7-1920x1080.pnghttps://players.brightcove.net/10203567001/dDZp7kuoR_default/index.html?videoId=6399915180112 https://www.cancernetwork.com/view/timing-systemic-therapy-and-locoregional-treatment-in-intermediate-stage-hcc2026-08-14https://cdn.sanity.io/images/0vv8moc6/cancernetwork/cabf8c772800a6812c20411dc26c291b2ee759d7-1920x1080.pnghttps://players.brightcove.net/10203567001/dDZp7kuoR_default/index.html?videoId=6399918632112 https://www.cancernetwork.com/view/how-ai-and-health-networks-are-democratizing-clinical-trial-access2026-08-13https://cdn.sanity.io/images/0vv8moc6/cancernetwork/25cfe4ab041727752bc043794637cae61d429761-1920x1080.pnghttps://players.brightcove.net/10203567001/dDZp7kuoR_default/index.html?videoId=6403169268112 https://www.cancernetwork.com/view/monitoring-and-mitigating-emergent-toxicities-during-car-t-cell-therapy2026-08-13https://cdn.sanity.io/images/0vv8moc6/cancernetwork/601710f44bebe48535cb37ab7df37b2973c08ac1-1920x1080.pnghttps://players.brightcove.net/10203567001/dDZp7kuoR_default/index.html?videoId=6402922145112 https://www.cancernetwork.com/view/arnt-expression-patterns-hold-promise-for-hif-1-inhibition-in-rcc-subtypes2026-08-12https://cdn.sanity.io/images/0vv8moc6/cancernetwork/b3eb1f5585b31d0457a4348fe3d3dbc5bf33b0d4-1920x1080.pnghttps://players.brightcove.net/10203567001/dDZp7kuoR_default/index.html?videoId=6403229734112 https://www.cancernetwork.com/view/bolstering-the-referral-process-for-car-t-cell-therapy-in-multiple-myeloma2026-08-12https://cdn.sanity.io/images/0vv8moc6/cancernetwork/13251dd8c46c9472160157d28b61a7a4180e566f-1920x1080.pnghttps://players.brightcove.net/10203567001/dDZp7kuoR_default/index.html?videoId=6402922313112 https://www.cancernetwork.com/view/expert-perspectives-on-sequencing-bcma-directed-therapies-in-relapsed-refractory-multiple-myeloma2026-08-12https://cdn.sanity.io/images/0vv8moc6/cancernetwork/50171b46bbf140c9a61bcc8068647893cf610187-886x498.pnghttps://players.brightcove.net/10203567001/dDZp7kuoR_default/index.html?videoId=6402776583112 https://www.cancernetwork.com/view/real-world-sequencing-patterns-of-bcma-directed-therapies-in-relapsed-refractory-multiple-myeloma2026-08-12https://cdn.sanity.io/images/0vv8moc6/cancernetwork/50171b46bbf140c9a61bcc8068647893cf610187-886x498.pnghttps://players.brightcove.net/10203567001/dDZp7kuoR_default/index.html?videoId=6402777550112 https://www.cancernetwork.com/view/asco-breakthroughs-affirm-value-of-biomarker-testing-in-lung-cancer2026-08-11https://cdn.sanity.io/images/0vv8moc6/cancernetwork/e25a4e69f87dca46158beccd0815e3e64f4b12c4-1920x1080.pnghttps://players.brightcove.net/10203567001/dDZp7kuoR_default/index.html?videoId=6402850241112 https://www.cancernetwork.com/view/building-brooklyn-drs-borgen-feinberg-on-breast-cancer-surgery-s-future2026-08-10https://cdn.sanity.io/images/0vv8moc6/cancernetwork/886cbd1067d29669395699e19976e3d203991099-1280x720.pnghttps://players.brightcove.net/10203567001/dDZp7kuoR_default/index.html?videoId=6402790102112 https://www.cancernetwork.com/view/future-sequencing-strategies-for-bcma-directed-therapies-in-relapsed-refractory-multiple-myeloma2026-08-10https://cdn.sanity.io/images/0vv8moc6/cancernetwork/ec80187078888b92e2a7be451eebdb324ea9cabc-1920x1080.pnghttps://players.brightcove.net/10203567001/dDZp7kuoR_default/index.html?videoId=6399475080112 https://www.cancernetwork.com/view/bispecific-antibodies-for-older-patients-with-relapsed-refractory-multiple-myeloma2026-08-10https://cdn.sanity.io/images/0vv8moc6/cancernetwork/ec80187078888b92e2a7be451eebdb324ea9cabc-1920x1080.pnghttps://players.brightcove.net/10203567001/dDZp7kuoR_default/index.html?videoId=6399474073112 https://www.cancernetwork.com/view/unmet-need-in-advanced-biliary-tract-cancer-and-the-rationale-for-chemoimmunotherapy2026-08-10https://cdn.sanity.io/images/0vv8moc6/cancernetwork/3c7a8b7d8cc2f7826679acabaa26445fe9d8d8d2-1920x1080.pnghttps://players.brightcove.net/10203567001/dDZp7kuoR_default/index.html?videoId=6402939946112 https://www.cancernetwork.com/view/does-patient-selection-inflate-car-t-outcomes-in-multiple-myeloma-2026-08-09https://cdn.sanity.io/images/0vv8moc6/cancernetwork/041f0015975d2e7ff4f56db89bd06f075da6761d-1920x1080.pnghttps://players.brightcove.net/10203567001/dDZp7kuoR_default/index.html?videoId=6402922235112 https://www.cancernetwork.com/view/understanding-the-training-credentialing-landscapes-for-end-of-life-doulas2026-08-08https://cdn.sanity.io/images/0vv8moc6/cancernetwork/a8030f88ac5afa44429321f98b2a126bc1489f22-1920x1080.pnghttps://players.brightcove.net/10203567001/dDZp7kuoR_default/index.html?videoId=6402778343112 https://www.cancernetwork.com/view/overcoming-barriers-to-intravesical-gemcitabine-system-in-high-risk-nmibc2026-08-08https://cdn.sanity.io/images/0vv8moc6/cancernetwork/002bbe5472eb1cba88bea16dbd6f1ee425e11fa6-1920x1080.pnghttps://players.brightcove.net/10203567001/dDZp7kuoR_default/index.html?videoId=6402861207112 https://www.cancernetwork.com/view/what-makes-an-optimal-car-t-cell-therapy-candidate-in-multiple-myeloma2026-08-07https://cdn.sanity.io/images/0vv8moc6/cancernetwork/b07c26859d0634e3b69f374412ed381f3bdfac42-1920x1080.pnghttps://players.brightcove.net/10203567001/dDZp7kuoR_default/index.html?videoId=6402922628112 https://www.cancernetwork.com/view/extending-drug-exposure-without-systemic-toxicity-in-nmibc-treatment2026-08-07https://cdn.sanity.io/images/0vv8moc6/cancernetwork/ffb42a31d3acc0d21cbbdb796f69275530ef2ed3-1920x1080.pnghttps://players.brightcove.net/10203567001/dDZp7kuoR_default/index.html?videoId=6402859949112 https://www.cancernetwork.com/view/why-car-t-cell-therapy-should-precede-bispecifics-in-multiple-myeloma2026-08-07https://cdn.sanity.io/images/0vv8moc6/cancernetwork/2b539188d9e59636bd0c314d7932ab1034718343-1920x1080.pnghttps://players.brightcove.net/10203567001/dDZp7kuoR_default/index.html?videoId=6402921550112 https://www.cancernetwork.com/view/how-end-of-life-doulas-help-patients-exercise-autonomy-in-their-care2026-08-07https://cdn.sanity.io/images/0vv8moc6/cancernetwork/9a1ef50dfdf0ae3c9fdeb5cfbd28726b9db0977e-1920x1080.pnghttps://players.brightcove.net/10203567001/dDZp7kuoR_default/index.html?videoId=6402780668112 https://www.cancernetwork.com/view/reviewing-the-emerald-1-trial-of-tace-with-durvalumab-and-bevacizumab2026-08-07https://cdn.sanity.io/images/0vv8moc6/cancernetwork/cabf8c772800a6812c20411dc26c291b2ee759d7-1920x1080.pnghttps://players.brightcove.net/10203567001/dDZp7kuoR_default/index.html?videoId=6399917270112 https://www.cancernetwork.com/view/considering-stride-for-child-pugh-b7-and-other-underrepresented-patients2026-08-07https://cdn.sanity.io/images/0vv8moc6/cancernetwork/cabf8c772800a6812c20411dc26c291b2ee759d7-1920x1080.pnghttps://players.brightcove.net/10203567001/dDZp7kuoR_default/index.html?videoId=6399916961112 https://www.cancernetwork.com/view/why-earlier-car-t-cell-therapy-may-benefit-patients-with-multiple-myeloma2026-08-06https://cdn.sanity.io/images/0vv8moc6/cancernetwork/cc9eabe858f8de9e0ddcdb2e9bab68a983224c97-1920x1080.pnghttps://players.brightcove.net/10203567001/dDZp7kuoR_default/index.html?videoId=6402921444112 https://www.cancernetwork.com/view/what-does-an-end-of-life-doula-do-for-patients-with-cancer2026-08-06https://cdn.sanity.io/images/0vv8moc6/cancernetwork/a1cf18fa43dfd3521714f52f5cd06e6dc14ebc9c-1920x1080.pnghttps://players.brightcove.net/10203567001/dDZp7kuoR_default/index.html?videoId=6402787813112 https://www.cancernetwork.com/view/navigating-reimbursement-and-timing-in-postoperative-ctdna-testing-for-mibc2026-08-06https://cdn.sanity.io/images/0vv8moc6/cancernetwork/8eab43878e44a24095868100147750bde59cc853-1920x1080.pnghttps://players.brightcove.net/10203567001/dDZp7kuoR_default/index.html?videoId=6402712072112 https://www.cancernetwork.com/view/invasive-lobular-carcinoma-diagnosis-trials-what-s-changing2026-08-06https://cdn.sanity.io/images/0vv8moc6/cancernetwork/249e429fb7ec46dde97215145d069b92147f4522-2400x1440.pnghttps://players.brightcove.net/10203567001/dDZp7kuoR_default/index.html?videoId=6402839213112 https://www.cancernetwork.com/view/cevostamab-trial-validates-fcrh5-as-a-multiple-myeloma-target2026-08-05https://cdn.sanity.io/images/0vv8moc6/cancernetwork/81ebd4144aa2f38b23ef42c62dda960bac86ae5a-1920x1080.pnghttps://players.brightcove.net/10203567001/dDZp7kuoR_default/index.html?videoId=6402470619112 https://www.cancernetwork.com/view/nccn-guidelines-navigating-ctdna-mrd-testing-in-evolving-mibc-paradigms2026-08-05https://cdn.sanity.io/images/0vv8moc6/cancernetwork/e995ca2a020c2caa884062432e1d946d508854d2-1920x1080.pnghttps://players.brightcove.net/10203567001/dDZp7kuoR_default/index.html?videoId=6402713853112 https://www.cancernetwork.com/view/clinical-implications-of-earlier-car-t-therapy-in-relapsed-refractory-multiple-myeloma2026-08-05https://cdn.sanity.io/images/0vv8moc6/cancernetwork/50171b46bbf140c9a61bcc8068647893cf610187-886x498.pnghttps://players.brightcove.net/10203567001/dDZp7kuoR_default/index.html?videoId=6402777362112 https://www.cancernetwork.com/view/cartitude-4-supports-earlier-car-t-use-in-relapsed-refractory-multiple-myeloma2026-08-05https://cdn.sanity.io/images/0vv8moc6/cancernetwork/50171b46bbf140c9a61bcc8068647893cf610187-886x498.pnghttps://players.brightcove.net/10203567001/dDZp7kuoR_default/index.html?videoId=6402777450112 https://www.cancernetwork.com/view/fixed-duration-cevostamab-yields-durable-responses-off-therapy2026-08-04https://cdn.sanity.io/images/0vv8moc6/cancernetwork/a6c19d6512817e03ef9e340814aa39cca9334a35-1920x1080.pnghttps://players.brightcove.net/10203567001/dDZp7kuoR_default/index.html?videoId=6402470035112 https://www.cancernetwork.com/view/ramy-sedhom-md-on-geriatric-oncology-trials-career-advice2026-08-04https://cdn.sanity.io/images/0vv8moc6/cancernetwork/df36f192c32d06f2b6d76ec40fd285b7c8deed6d-1280x720.pnghttps://players.brightcove.net/10203567001/dDZp7kuoR_default/index.html?videoId=6402771649112 https://www.cancernetwork.com/view/case-discussion-high-risk-cll-with-del-17p-and-clinical-summary2026-08-04https://cdn.sanity.io/images/0vv8moc6/cancernetwork/28de994e5bd7f6e3b1af99ee70a877443ea899a8-928x520.pnghttps://players.brightcove.net/10203567001/dDZp7kuoR_default/index.html?videoId=6399477688112 https://www.cancernetwork.com/view/the-beginning-of-the-immunotherapy-deluge-in-multiple-myeloma2026-08-03https://cdn.sanity.io/images/0vv8moc6/cancernetwork/1abdb371044abf6f564aa460e58e70171c0d14f5-1920x1080.pnghttps://players.brightcove.net/10203567001/dDZp7kuoR_default/index.html?videoId=6402423526112 https://www.cancernetwork.com/view/bringing-robotic-mastectomy-to-a-regional-health-system-expands-access2026-08-03https://cdn.sanity.io/images/0vv8moc6/cancernetwork/0166bf44417f9586778f0078e63b5b327f32f7f3-1920x1080.jpghttps://players.brightcove.net/10203567001/dDZp7kuoR_default/index.html?videoId=6402408529112 https://www.cancernetwork.com/view/integrating-majestec-9-data-into-treatment-decisions-for-relapsed-refractory-multiple-myeloma2026-08-03https://cdn.sanity.io/images/0vv8moc6/cancernetwork/ec80187078888b92e2a7be451eebdb324ea9cabc-1920x1080.pnghttps://players.brightcove.net/10203567001/dDZp7kuoR_default/index.html?videoId=6399473601112 https://www.cancernetwork.com/view/sequencing-car-t-cell-therapy-and-bispecific-antibodies-at-first-relapse-in-relapsed-refractory-multiple-myeloma2026-08-03https://cdn.sanity.io/images/0vv8moc6/cancernetwork/ec80187078888b92e2a7be451eebdb324ea9cabc-1920x1080.pnghttps://players.brightcove.net/10203567001/dDZp7kuoR_default/index.html?videoId=6399474173112 https://www.cancernetwork.com/view/teclistamab-talquetamab-hits-record-low-hazard-ratio-in-multiple-myeloma2026-08-02https://cdn.sanity.io/images/0vv8moc6/cancernetwork/ad1580d97699e83bddd3d88fa50fe40d7f26034e-1920x1080.pnghttps://players.brightcove.net/10203567001/dDZp7kuoR_default/index.html?videoId=6402424126112 https://www.cancernetwork.com/view/lateral-axillary-incision-preferred-for-da-vinci-single-port-mastectomy2026-08-02https://cdn.sanity.io/images/0vv8moc6/cancernetwork/49284a5b7a2930671d574585e906d6bf852c1d67-1920x1080.jpghttps://players.brightcove.net/10203567001/dDZp7kuoR_default/index.html?videoId=6402280014112 https://www.cancernetwork.com/view/combining-kras-inhibitors-with-pi3k-and-checkpoint-blockade-to-improve-response-durability2026-08-01https://cdn.sanity.io/images/0vv8moc6/cancernetwork/8cbf3e49af5b673088e5fe912420efd5619d8ad9-1920x1080.jpghttps://players.brightcove.net/10203567001/dDZp7kuoR_default/index.html?videoId=6402473395112 https://www.cancernetwork.com/view/rasolute-302-data-signal-a-new-era-for-pancreatic-cancer-drug-development2026-07-31https://cdn.sanity.io/images/0vv8moc6/cancernetwork/ce4f11205d0c78252ab8e8defd8727508d049346-1920x1080.jpghttps://players.brightcove.net/10203567001/dDZp7kuoR_default/index.html?videoId=6402475352112 https://www.cancernetwork.com/view/sneak-peek-practical-car-t-cell-use-in-multiple-myeloma-care2026-07-31https://cdn.sanity.io/images/0vv8moc6/cancernetwork/d5fe7ee7671f0fb147f3dc21e2b7c941a19d9df1-1200x674.jpghttps://players.brightcove.net/10203567001/dDZp7kuoR_default/index.html?videoId=6402521583112 https://www.cancernetwork.com/view/disease-biology-aromatase-inhibitor-driven-resistance-and-esr1-emergence2026-07-31https://cdn.sanity.io/images/0vv8moc6/cancernetwork/7899b4dd5458f963c1983b139b4b8ee664948709-1920x1080.pnghttps://players.brightcove.net/10203567001/dDZp7kuoR_default/index.html?videoId=6402534727112 https://www.cancernetwork.com/view/3d-visualization-with-da-vinci-single-port-boosts-breast-surgery-precision2026-07-31https://cdn.sanity.io/images/0vv8moc6/cancernetwork/a8b5840600acc186355db1fee910819bf438db06-1920x1080.jpghttps://players.brightcove.net/10203567001/dDZp7kuoR_default/index.html?videoId=6402278025112 https://www.cancernetwork.com/view/reviewing-the-sierra-trial-of-stride-in-poor-prognosis-hcc2026-07-31https://cdn.sanity.io/images/0vv8moc6/cancernetwork/cabf8c772800a6812c20411dc26c291b2ee759d7-1920x1080.pnghttps://players.brightcove.net/10203567001/dDZp7kuoR_default/index.html?videoId=6399916576112 https://www.cancernetwork.com/view/car-t-cell-therapy-could-soon-expand-into-non-oncology-indications2026-07-30https://cdn.sanity.io/images/0vv8moc6/cancernetwork/6aa845fc8fb89b96c7c3afe1bc1427343880e97b-1920x1080.pnghttps://players.brightcove.net/10203567001/dDZp7kuoR_default/index.html?videoId=6402339870112 https://www.cancernetwork.com/view/taking-a-cautionary-view-on-radical-trial-data-in-bone-metastatic-rcc2026-07-30https://cdn.sanity.io/images/0vv8moc6/cancernetwork/bf3665949095fa027d7b46ea6cb5e43e573afaa1-1920x1080.pnghttps://players.brightcove.net/10203567001/dDZp7kuoR_default/index.html?videoId=6402349422112 https://www.cancernetwork.com/view/linvoseltamab-data-and-clinical-perspectives-in-relapsed-refractory-multiple-myeloma2026-07-29https://cdn.sanity.io/images/0vv8moc6/cancernetwork/50171b46bbf140c9a61bcc8068647893cf610187-886x498.pnghttps://players.brightcove.net/10203567001/dDZp7kuoR_default/index.html?videoId=6402431960112 https://www.cancernetwork.com/view/introduction-to-bcma-directed-therapies-in-relapsed-refractory-multiple-myeloma2026-07-29https://cdn.sanity.io/images/0vv8moc6/cancernetwork/50171b46bbf140c9a61bcc8068647893cf610187-886x498.pnghttps://players.brightcove.net/10203567001/dDZp7kuoR_default/index.html?videoId=6402433689112 https://www.cancernetwork.com/view/weighing-the-catabolic-effects-of-lenvatinib-everolimus-vs-soc-in-ccrcc2026-07-29https://cdn.sanity.io/images/0vv8moc6/cancernetwork/21148cf2f127527ec84b3132bdb866987ffed219-1920x1080.pnghttps://players.brightcove.net/10203567001/dDZp7kuoR_default/index.html?videoId=6402351923112 https://www.cancernetwork.com/view/equitable-access-to-cellular-therapy-requires-more-than-certification2026-07-29https://cdn.sanity.io/images/0vv8moc6/cancernetwork/d6e888c9ad6d9471b9d6587d679bf32729cce728-1920x1080.pnghttps://players.brightcove.net/10203567001/dDZp7kuoR_default/index.html?videoId=6402341465112 https://www.cancernetwork.com/view/navigating-insurance-hurdles-for-oral-aml-therapy-access2026-07-28https://cdn.sanity.io/images/0vv8moc6/cancernetwork/b6e9089fe15f2900c03a79ae3448d52bcd0f70a9-1920x1080.pnghttps://players.brightcove.net/10203567001/dDZp7kuoR_default/index.html?videoId=6401052496112 https://www.cancernetwork.com/view/case-discussion-treatment-naive-patient-with-cll-with-unmutated-ighv2026-07-28https://cdn.sanity.io/images/0vv8moc6/cancernetwork/28de994e5bd7f6e3b1af99ee70a877443ea899a8-928x520.pnghttps://players.brightcove.net/10203567001/dDZp7kuoR_default/index.html?videoId=6399477192112 https://www.cancernetwork.com/view/mechanism-of-action-switching-and-treatment-selection-after-progression-in-cll2026-07-28https://cdn.sanity.io/images/0vv8moc6/cancernetwork/28de994e5bd7f6e3b1af99ee70a877443ea899a8-928x520.pnghttps://players.brightcove.net/10203567001/dDZp7kuoR_default/index.html?videoId=6399476979112 https://www.cancernetwork.com/view/managing-gi-adverse-effects-to-keep-patients-on-oral-aml-therapy2026-07-27https://cdn.sanity.io/images/0vv8moc6/cancernetwork/1d23638c2aa9b797716f4e422453020de3303403-1920x1080.pnghttps://players.brightcove.net/10203567001/dDZp7kuoR_default/index.html?videoId=6401052251112 https://www.cancernetwork.com/view/choosing-among-bcma-directed-bispecific-antibodies-in-relapsed-refractory-multiple-myeloma2026-07-27https://cdn.sanity.io/images/0vv8moc6/cancernetwork/ec80187078888b92e2a7be451eebdb324ea9cabc-1920x1080.pnghttps://players.brightcove.net/10203567001/dDZp7kuoR_default/index.html?videoId=6399473011112 https://www.cancernetwork.com/view/optimizing-dosing-strategies-for-bispecific-antibodies-in-relapsed-refractory-multiple-myeloma2026-07-27https://cdn.sanity.io/images/0vv8moc6/cancernetwork/ec80187078888b92e2a7be451eebdb324ea9cabc-1920x1080.pnghttps://players.brightcove.net/10203567001/dDZp7kuoR_default/index.html?videoId=6399474578112 https://www.cancernetwork.com/view/car-t-cell-expansion-predicts-toxicity-but-not-always-efficacy2026-07-26https://cdn.sanity.io/images/0vv8moc6/cancernetwork/4144e424242849485960702ceb8dffbb7e6d026f-1920x1080.pnghttps://players.brightcove.net/10203567001/dDZp7kuoR_default/index.html?videoId=6401756144112 https://www.cancernetwork.com/view/real-world-arc-data-reassure-venetoclax-dose-flexibility-in-aml2026-07-26https://cdn.sanity.io/images/0vv8moc6/cancernetwork/f33a764446927b2fb1169440c417b7410b62e6e2-1920x1080.pnghttps://players.brightcove.net/10203567001/dDZp7kuoR_default/index.html?videoId=6401218624112 https://www.cancernetwork.com/view/breast-surgeon-reflects-on-technology-reliance-after-biopsy-needle-recall2026-07-25https://cdn.sanity.io/images/0vv8moc6/cancernetwork/e7a428fa841c86547362a4e5c42cc525b50a5dad-1920x1080.pnghttps://players.brightcove.net/10203567001/dDZp7kuoR_default/index.html?videoId=6400557502112 https://www.cancernetwork.com/view/optimizing-surveillance-protocols-after-focal-therapy-for-prostate-cancer2026-07-24https://cdn.sanity.io/images/0vv8moc6/cancernetwork/8d2cffc1360155f4e92b375429b07ab66bc50c5c-1920x1080.pnghttps://players.brightcove.net/10203567001/dDZp7kuoR_default/index.html?videoId=6401938915112 https://www.cancernetwork.com/view/rasolute-302-and-the-future-of-pancreatic-cancer-treatment-paul-oberstein-md-on-the-kras-breakthrough2026-07-24https://cdn.sanity.io/images/0vv8moc6/cancernetwork/affe245fcbd56e0607228ade4e8c5b0851c2f930-1909x1044.pnghttps://players.brightcove.net/10203567001/dDZp7kuoR_default/index.html?videoId=6401764112112 https://www.cancernetwork.com/view/defining-new-thresholds-for-precisely-mitigating-car-t-toxicity2026-07-24https://cdn.sanity.io/images/0vv8moc6/cancernetwork/de386e81f0498a8812025e864a754d79d552374e-1920x1080.pnghttps://players.brightcove.net/10203567001/dDZp7kuoR_default/index.html?videoId=6401927436112 https://www.cancernetwork.com/view/how-to-speak-with-patients-about-potential-changes-to-care-during-biopsy-needle-delays2026-07-24https://cdn.sanity.io/images/0vv8moc6/cancernetwork/3eaf0189c892cb480b5c18ede2fa17a8d5157de0-1920x1080.pnghttps://players.brightcove.net/10203567001/dDZp7kuoR_default/index.html?videoId=6400556025112 https://www.cancernetwork.com/view/managing-ipilimumab-dosing-and-immune-related-toxicity-in-frontline-hcc2026-07-24https://cdn.sanity.io/images/0vv8moc6/cancernetwork/cabf8c772800a6812c20411dc26c291b2ee759d7-1920x1080.pnghttps://players.brightcove.net/10203567001/dDZp7kuoR_default/index.html?videoId=6399917561112 https://www.cancernetwork.com/view/relapsed-refractory-multiple-myeloma-future-directions-for-t-cell-redirecting-therapies2026-07-24https://cdn.sanity.io/images/0vv8moc6/cancernetwork/15c7813dd2953358e65647da81919a6870316f0d-1920x1080.pnghttps://players.brightcove.net/10203567001/dDZp7kuoR_default/index.html?videoId=6399374024112 https://www.cancernetwork.com/view/relapsed-refractory-multiple-myeloma-sequencing-car-t-cell-therapy-and-bispecific-antibodies2026-07-24https://cdn.sanity.io/images/0vv8moc6/cancernetwork/15c7813dd2953358e65647da81919a6870316f0d-1920x1080.pnghttps://players.brightcove.net/10203567001/dDZp7kuoR_default/index.html?videoId=6399375487112 https://www.cancernetwork.com/view/reviewing-the-checkmate-9dw-trial-of-nivolumab-plus-ipilimumab-in-unresectable-hcc2026-07-24https://cdn.sanity.io/images/0vv8moc6/cancernetwork/cabf8c772800a6812c20411dc26c291b2ee759d7-1920x1080.pnghttps://players.brightcove.net/10203567001/dDZp7kuoR_default/index.html?videoId=6399918531112 https://www.cancernetwork.com/view/the-role-of-breast-surgeons-amid-a-biopsy-needle-shortage2026-07-22https://cdn.sanity.io/images/0vv8moc6/cancernetwork/b030cb79372c1559379485903d9550f2a5759234-1920x1080.pnghttps://players.brightcove.net/10203567001/dDZp7kuoR_default/index.html?videoId=6400555422112 https://www.cancernetwork.com/view/optimal-sequencing-of-bispecific-antibodies-and-car-t-cells-remains-unclear2026-07-22https://cdn.sanity.io/images/0vv8moc6/cancernetwork/5dc453eb895d6b6185226f16af8a44d551994d74-1920x1080.pnghttps://players.brightcove.net/10203567001/dDZp7kuoR_default/index.html?videoId=6401665510112 https://www.cancernetwork.com/view/sequencing-beyond-frontline-resistance-later-line-options-and-emerging-directions-in-egfr-mutant-nsclc2026-07-22https://cdn.sanity.io/images/0vv8moc6/cancernetwork/37a72e2f580b281e1dbbeb19cd2bf9c74435f210-1920x1080.pnghttps://players.brightcove.net/10203567001/dDZp7kuoR_default/index.html?videoId=6401829363112 https://www.cancernetwork.com/view/case-study-individualizing-frontline-therapy-in-an-older-patient-with-comorbidities-and-limited-support2026-07-22https://cdn.sanity.io/images/0vv8moc6/cancernetwork/37a72e2f580b281e1dbbeb19cd2bf9c74435f210-1920x1080.pnghttps://players.brightcove.net/10203567001/dDZp7kuoR_default/index.html?videoId=6401829071112 https://www.cancernetwork.com/view/case-study-selecting-frontline-therapy-in-higher-risk-egfr-mutant-nsclc-with-brain-metastases2026-07-22https://cdn.sanity.io/images/0vv8moc6/cancernetwork/37a72e2f580b281e1dbbeb19cd2bf9c74435f210-1920x1080.pnghttps://players.brightcove.net/10203567001/dDZp7kuoR_default/index.html?videoId=6401827211112 https://www.cancernetwork.com/view/managing-patient-preferences-and-expectations-in-frontline-egfr-mutant-nsclc2026-07-22https://cdn.sanity.io/images/0vv8moc6/cancernetwork/37a72e2f580b281e1dbbeb19cd2bf9c74435f210-1920x1080.pnghttps://players.brightcove.net/10203567001/dDZp7kuoR_default/index.html?videoId=6401828498112 https://www.cancernetwork.com/view/the-mariposa-regimen-efficacy-and-toxicity-management-in-frontline-egfr-mutant-nsclc2026-07-22https://cdn.sanity.io/images/0vv8moc6/cancernetwork/37a72e2f580b281e1dbbeb19cd2bf9c74435f210-1920x1080.pnghttps://players.brightcove.net/10203567001/dDZp7kuoR_default/index.html?videoId=6401828969112 https://www.cancernetwork.com/view/the-flaura2-regimen-adding-chemotherapy-to-targeted-therapy-in-frontline-egfr-mutant-nsclc2026-07-22https://cdn.sanity.io/images/0vv8moc6/cancernetwork/37a72e2f580b281e1dbbeb19cd2bf9c74435f210-1920x1080.pnghttps://players.brightcove.net/10203567001/dDZp7kuoR_default/index.html?videoId=6401828679112 https://www.cancernetwork.com/view/establishing-the-frontline-monotherapy-backbone-in-egfr-mutant-nsclc2026-07-22https://cdn.sanity.io/images/0vv8moc6/cancernetwork/37a72e2f580b281e1dbbeb19cd2bf9c74435f210-1920x1080.pnghttps://players.brightcove.net/10203567001/dDZp7kuoR_default/index.html?videoId=6401827819112 https://www.cancernetwork.com/view/individualizing-frontline-treatment-selection-in-egfr-mutant-nsclc2026-07-22https://cdn.sanity.io/images/0vv8moc6/cancernetwork/37a72e2f580b281e1dbbeb19cd2bf9c74435f210-1920x1080.pnghttps://players.brightcove.net/10203567001/dDZp7kuoR_default/index.html?videoId=6401666786112 https://www.cancernetwork.com/view/comprehensive-biomarker-testing-to-guide-frontline-therapy-in-egfr-mutant-nsclc2026-07-22https://cdn.sanity.io/images/0vv8moc6/cancernetwork/37a72e2f580b281e1dbbeb19cd2bf9c74435f210-1920x1080.pnghttps://players.brightcove.net/10203567001/dDZp7kuoR_default/index.html?videoId=6401666103112 https://www.cancernetwork.com/view/second-line-treatment-strategies-and-emerging-challenges2026-07-22https://cdn.sanity.io/images/0vv8moc6/cancernetwork/bf18124ff0b2b4bf90e121d3c7946610edb70425-918x518.pnghttps://players.brightcove.net/10203567001/dDZp7kuoR_default/index.html?videoId=6398157142112 https://www.cancernetwork.com/view/considering-car-t-vs-bispecific-antibodies-in-r-r-follicular-lymphoma2026-07-21https://cdn.sanity.io/images/0vv8moc6/cancernetwork/9ed00b926dad9151324f0842a420729ca3ce5d86-1920x1080.pnghttps://players.brightcove.net/10203567001/dDZp7kuoR_default/index.html?videoId=6401669934112 https://www.cancernetwork.com/view/delayed-neurotoxicity-remains-a-challenge-in-car-t-cell-therapy2026-07-21https://cdn.sanity.io/images/0vv8moc6/cancernetwork/ad69bcf88007ddad6c316ddf3870603fbc018593-1920x1080.pnghttps://players.brightcove.net/10203567001/dDZp7kuoR_default/index.html?videoId=6401667175112 https://www.cancernetwork.com/view/breast-surgeon-explains-how-her-team-avoided-delays-after-needle-recall2026-07-21https://cdn.sanity.io/images/0vv8moc6/cancernetwork/8f3e4e103b83e4c3eadfb2a0f39537d365131224-1920x1080.pnghttps://players.brightcove.net/10203567001/dDZp7kuoR_default/index.html?videoId=6400557402112 https://www.cancernetwork.com/view/pirtobrutinib-data-and-sequencing-after-covalent-btk-inhibitor-progression2026-07-21https://cdn.sanity.io/images/0vv8moc6/cancernetwork/28de994e5bd7f6e3b1af99ee70a877443ea899a8-928x520.pnghttps://players.brightcove.net/10203567001/dDZp7kuoR_default/index.html?videoId=6399475725112 https://www.cancernetwork.com/view/sequencing-considerations-and-elderly-patient-data-in-cll2026-07-21https://cdn.sanity.io/images/0vv8moc6/cancernetwork/28de994e5bd7f6e3b1af99ee70a877443ea899a8-928x520.pnghttps://players.brightcove.net/10203567001/dDZp7kuoR_default/index.html?videoId=6399476127112 https://www.cancernetwork.com/view/clinical-scenario---long-term-toxicity-management-in-her2-positive-metastatic-breast-cancer2026-07-21https://cdn.sanity.io/images/0vv8moc6/cancernetwork/96cca548b474372824afc8f87879ac63c2475b1d-1920x1080.pnghttps://players.brightcove.net/10203567001/dDZp7kuoR_default/index.html?videoId=6398681200112 https://www.cancernetwork.com/view/ascertain-v-data-support-oral-hma-combination-as-aml-frontline-option2026-07-20https://cdn.sanity.io/images/0vv8moc6/cancernetwork/340e3bf6af57a5242c67f55dfd42e03b2dea13bb-1920x1080.pnghttps://players.brightcove.net/10203567001/dDZp7kuoR_default/index.html?videoId=6401051224112 https://www.cancernetwork.com/view/managing-safety-and-infection-risk-with-bispecific-antibodies-in-relapsed-refractory-multiple-myeloma2026-07-20https://cdn.sanity.io/images/0vv8moc6/cancernetwork/ec80187078888b92e2a7be451eebdb324ea9cabc-1920x1080.pnghttps://players.brightcove.net/10203567001/dDZp7kuoR_default/index.html?videoId=6399473009112 https://www.cancernetwork.com/view/future-directions-and-key-takeaways-in-the-field-of-cscc2026-07-20https://cdn.sanity.io/images/0vv8moc6/cancernetwork/67b35a74c0a9ab7f22a9299700321e0c7799e0bc-1920x1080.jpghttps://players.brightcove.net/10203567001/dDZp7kuoR_default/index.html?videoId=6398070681112 https://www.cancernetwork.com/view/clinical-scenarios-matching-regimen-to-patient-profile2026-07-20https://cdn.sanity.io/images/0vv8moc6/cancernetwork/1fe7502990a39da4a57f9caf06786cff7c2c8bb2-1920x1080.pnghttps://players.brightcove.net/10203567001/dDZp7kuoR_default/index.html?videoId=6399726164112 https://www.cancernetwork.com/view/immunocompromised-patients-with-cscc-future-directions-and-closing-pearls2026-07-20https://cdn.sanity.io/images/0vv8moc6/cancernetwork/29beccff572cb2b27e5107197062d0fbe40abab7-1920x1080.pnghttps://players.brightcove.net/10203567001/dDZp7kuoR_default/index.html?videoId=6399393553112 https://www.cancernetwork.com/view/biomarkers-and-immunocompromised-patients2026-07-20https://cdn.sanity.io/images/0vv8moc6/cancernetwork/67b35a74c0a9ab7f22a9299700321e0c7799e0bc-1920x1080.jpghttps://players.brightcove.net/10203567001/dDZp7kuoR_default/index.html?videoId=6398070105112 https://www.cancernetwork.com/view/multidisciplinary-coordination-biomarkers-and-immunocompromised-patients-with-cscc2026-07-20https://cdn.sanity.io/images/0vv8moc6/cancernetwork/29beccff572cb2b27e5107197062d0fbe40abab7-1920x1080.pnghttps://players.brightcove.net/10203567001/dDZp7kuoR_default/index.html?videoId=6399391785112 https://www.cancernetwork.com/view/resistance-biology-mariposa-vs-flaura2-reshaping-debate2026-07-20https://cdn.sanity.io/images/0vv8moc6/cancernetwork/1fe7502990a39da4a57f9caf06786cff7c2c8bb2-1920x1080.pnghttps://players.brightcove.net/10203567001/dDZp7kuoR_default/index.html?videoId=6399727452112 https://www.cancernetwork.com/view/applying-majestec-data-across-patient-populations-in-relapsed-refractory-multiple-myeloma2026-07-20https://cdn.sanity.io/images/0vv8moc6/cancernetwork/ec80187078888b92e2a7be451eebdb324ea9cabc-1920x1080.pnghttps://players.brightcove.net/10203567001/dDZp7kuoR_default/index.html?videoId=6399474174112